Sai Life Sciences, one of India's fastest growing contract development and manufacturing organizations (CDMOs), has inaugurated its new Research and Technology (R&T) Center in Hyderabad, India.
 
Built with an aspiration to achieve the best global benchmarks in lab infrastructure, the new R&T facility features several unique aspects such as intelligent and ergonomic lab design to enhance safety and productivity, advanced automation for seamless data capture during process development, lean and 5S approach to enhance productivity and collaborative workspaces for engendering innovation.

 
"Our philosophy behind building this new facility was to go beyond what the norm is in India and to create what our global innovator partners expect from their in-house capabilities," said Krishna Kanumuri, chief executive officer and managing director. Sai Life Sciences. "We are an example of what is possible in Hyderabad's rich life sciences ecosystem. Today, as we build world class R&D capabilities and invest in nurturing talent with deep domain expertise, I can unhesitatingly say, Hyderabad is truly a city where pharma dreams are made."
 
The new 83,000 square foot facility houses state-of-the-art research capabilities and advanced technology platforms, augmenting the company's capabilities in providing scientific solutions to its pharma and biotech innovator customers globally. It has 24 chemistry labs with 250 fume hoods, analytical labs, fully equipped technology suite and a dedicated process safety lab.
 
Sai Life Sciences began a process of organizational transformation in 2019 reinventing itself as a new generation global CDMO. Through this initiative, named Sai Nxt, the company is investing over $150 million to expand and upgrade its R&D and manufacturing facilities, induct top-notch global scientific and leadership talent, strengthen automation and data systems, and above all raise the bar for safety, quality and customer focus.